Viewing nowRistrol Tablet 20 Milligrams (Atorvastatin Calcium Hydrate)
Atorvastatin Calcium Hydrate 21.69mg
Tablet · Prescription medication
Korea Prime Pharmaceutical Co., Ltd.

MFDS item code 201400193 · Approved 2014.01.16 · Insurance code 663606060
Improvement of hyperlipidemia, prevention of cardiovascular diseases (e.g., myocardial infarction and stroke)
This medication helps reduce the risk of various cardiovascular diseases. It primarily lowers the risk of myocardial infarction and stroke in adults with risk factors for coronary artery disease and patients with type 2 diabetes, while also reducing the risk of vascular interventions and angina. Additionally, it effectively reduces the risk of overall cardiovascular events, along with the risk of hospitalization for congestive heart failure in patients with demonstrated cardiovascular disease. Alongside this, it is used as an adjunct to diet to lower cholesterol and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia, increasing HDL cholesterol levels. It provides effective adjunctive therapy even when diet alone is insufficient. It is also used to lower cholesterol levels in pediatric patients with heterozygous familial hypercholesterolemia. In summary, this drug improves various risk factors for cardiovascular disease, manages hyperlipidemia, and plays a crucial role in the prevention of heart and vascular diseases.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This drug may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily; however, patients requiring a greater reduction in LDL cholesterol may start at 20 mg or 40 mg once daily (40 mg is only for patients requiring an LDL cholesterol reduction of 45 % or more). This drug is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this drug should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose adjusted accordingly. As the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the response to treatment. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. Administer this drug in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: The efficacy and safety in patients aged 70 years or older are similar to those in the general adult population.
2. Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years) 10 ~ 17 years: The recommended initial dose is 10 mg of this drug once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this drug higher than 20 mg in pediatric patients). Adjust the dose as appropriate according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer.
This medication may cause muscle-related issues; therefore, if symptoms such as muscle pain, muscle weakness, or muscle cramps occur, discontinue use immediately and consult a physician. Treatment should be stopped if creatine kinase (CK) levels are abnormally high or if myopathy is suspected. This drug may affect liver function; therefore, it should not be used in cases of liver disease or when liver function test results are elevated, and regular liver function tests must be performed during treatment. Pregnant or potentially pregnant women and breastfeeding women should not take this medication. Patients with a history of alcohol abuse or liver disease should use this product with caution, and it is also not recommended for children under 10 years of age. This medication may interact with other drugs, especially certain antibiotics, antifungals, HIV treatments, and some lipid-lowering agents, so care should be taken when used in conjunction with them. If symptoms such as muscle pain, weakness, fever, or malaise occur during treatment, inform a doctor immediately, and blood tests may be needed to check for muscle damage. This medication may affect blood sugar levels, so patients at risk for diabetes should manage their blood sugar levels closely. Older adults or patients with decreased kidney function are at higher risk for myopathy and should use this drug with increased caution. There is no specific antidote for overdose, so treatment should be symptomatic, with monitoring of liver function and muscle status. This medication should be stored out of the reach of children and kept in its original container for safety.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture; therefore, it must be stored in a tightly sealed container. Additionally, it is best to keep the medication at room temperature between 1 to 30 degrees Celsius, away from extreme heat or cold.
For domestic use: white oval film-coated tablet For export: white round film-coated tablet
For domestic use - 30 tablets/bottle, For domestic use - 100 tablets/bottle, For export - 30 tablets/ptp
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Hydrate 21.69mg
Tablet · Prescription medication
Korea Prime Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.